MOU signed between the British Embassy in Korea, the British Chamber of Commerce in Korea, and the Korea GSK for World Vaccination Week

Apr 28, 2025

MOU signed between the British Embassy in Korea, the British Chamber of Commerce in Korea, and the Korea GSK for World Vaccination Week
◇From left, GSK CEO Maurizio Borgata, Ambassador Colin Crooks of the British Embassy in Korea, and Sean Blakely, Chairman of the British Chamber of Commerce in Korea, signed a `Three-Party Agreement on Business to Expand Adult Vaccination in Korea' on the 25th and take a commemorative photo. Photo courtesy = GSK Korea



On the occasion of World Immunization Week, the British Embassy in Korea, the British Chamber of Commerce in Korea, and GSK Korea signed a three-way memorandum of understanding (MOU) to expand adult vaccination in Korea on the 25th.

The World Vaccination Week, established by the World Health Organization (WHO) in 2012, is the last week of April every year (4/24~4/30), during which various activities are carried out to promote the importance and value of vaccination in each country so that everyone can prevent infectious diseases through vaccination. In Korea, the Korea Centers for Disease Control and Prevention held an international symposium commemorating World Vaccination Week from the 23rd to the 24th, and various domestic and foreign speakers, including GSK, discussed the necessity of expanding adult vaccination, the latest research results and global trends of vaccines, and ways to develop vaccination policies in the future.

As Korea enters an ultra-aging society, expanding vaccinations and improving vaccine access for adults is emerging as an urgent policy task, but currently, the government provides only two vaccines for the elderly over 65 years of age through the National Essential Vaccination (NIP). Accordingly, the British Embassy in Korea, the British Chamber of Commerce and Industry in Korea, and GSK will form a partnership to promote various programs to promote the value and necessity of adult vaccination, including the elderly population, and to expand the current national essential vaccination system focused on children to a feasible life cycle.




The signing ceremony was attended by key officials from each institution and company, including Ambassador Colin Crookes of the British Embassy in Korea, Sean Blakeley, president of the British Chamber of Commerce in Korea, and CEO of GSK Maurizio Borgata, to strengthen their commitment to cooperative activities aimed at expanding adult vaccination.

Maurizio Borgata, CEO of GSK Korea, said "It is very meaningful to cooperate with the British Embassy in Korea and the British Chamber of Commerce in order to promote the importance of adult vaccination and increase vaccine access in Korea, which has entered a super-aged society. GSK is a global leader in the vaccine sector, with seven types of vaccines participating in Korea's national vaccination project and playing an important role in preventing infectious diseases in infants and young children""Korea GSK will also do its best to provide innovative vaccines, continue close cooperation with key partners, and expand adult vaccination with the recognition that preparing for vaccine-preventable diseases is key to an aging society.""






This article was translated by Naver AI translator.